Short answer
Stride, Inc. (LRN) filed an 8-K current report with the SEC on October 9, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item 1.01 (Entry into a Material Definitive Agreement). Activist settlement with Fivespan adds Dylan Haggart and Steven Guttentag to Stride’s board, increasing investor influence.
Stride, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- Activist settlement with Fivespan adds Dylan Haggart and Steven Guttentag to Stride’s board, increasing investor influence
- Haggart joins October 30, 2026, while Guttentag becomes an immediate observer and director after the 2026 Annual Meeting
- Newly formed Capital Allocation Committee will review capital structure and allocation strategy
- Fivespan withdrew its director nominations, shareholder proposal and Section 220 books-and-records demand
- Standstill provisions limit further activism until 30 days before the 2027 nomination deadline, subject to specified termination events
Item 5.02 · Departure/Election of Directors or Officers
- Board appointed Michael Haggart as director, replacing Allison Lawrence’s vacancy, with nomination for election at the 2026 Annual Meeting
- Lawrence’s resignation was not due to operational, policy or practice disagreements; she remains a non-voting observer until reappointment
- Board size rises from eight to ten after the 2026 Annual Meeting, with nine independent directors
- Haggart adds investment and governance expertise; Guttentag adds more than 30 years of K-12 education technology experience
- Appointments stem from a Cooperation Agreement, signaling shareholder engagement and potential influence over capital allocation and compensation oversight
Item 7.01 · Regulation FD Disclosure
- Cooperation Agreement announced, signaling a negotiated governance arrangement with unspecified strategic or shareholder implications
- Mr. Haggart appointed to the Board effective on the stated Appointment Date and Time
- Dr. Guttentag named Board Observer, with expected Board appointment after the 2026 Annual Meeting
- Capital Allocation Committee formed to review capital deployment priorities
- Target capital structure and future cash-flow allocation framework expected within three months, potentially affecting buybacks, acquisitions and other uses of capital
Item EX-99.1 · Exhibit EX-99.1
- Board appointments for Steven Guttentag and Fivespan’s Dylan Haggart, adding education technology and activist-investor expertise
- New Capital Allocation Committee, co-chaired by independent director Brian Shepherd and Haggart
- Shareholder input to shape capital allocation priorities and target capital structure
- Target capital structure and cash-flow allocation framework expected within three months
- Cooperation agreement with significant shareholder Fivespan, ahead of December 10, 2026 annual meeting
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Stride, Inc. 8-K filings
Get the next LRN 8-K as it lands
Follow LRN for push alerts, or ask the research agent what this filing means.